Daclizumab (trade name Zinbryta) is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple...
18 KB (1,656 words) - 19:23, 6 November 2024
mouse/human anti-Tac antibodies in the year 1998: basiliximab (Simulect) and daclizumab (Zenapax). These drugs act by binding the IL-2a receptor's α chain, preventing...
29 KB (3,379 words) - 21:09, 30 December 2024
spondylitis by their ability to bind to and inhibit TNF-α. Basiliximab and daclizumab inhibit IL-2 on activated T cells and thereby help prevent acute rejection...
48 KB (4,972 words) - 04:27, 21 December 2024
dacarbazine (INN) dacemazine (INN) dacetuzumab (USAN, INN) dacisteine (INN) daclizumab (INN) dacopafant (INN) dactinomycin (INN) dacuronium bromide (INN) Dafiro...
6 KB (331 words) - 04:31, 10 November 2024
humanized anti-Tac (daclizumab, Zenapax) and the antibody armed with toxins or alpha and beta-emitting radionuclides. He showed that daclizumab contributes to...
10 KB (1,411 words) - 22:01, 23 July 2023
(+hyaluronidase) Ozanimod Ponesimod Siponimod Teriflunomide Other treatments Former Daclizumab Research in multiple sclerosis Demyelinating diseases Other List of multiple...
173 KB (18,318 words) - 15:33, 3 January 2025
(vemurafenib), for late-stage V600E BRAF mutation-positive melanoma. Zenapax (daclizumab), for the prevention of acute transplant rejection. Diabetes management...
67 KB (5,738 words) - 11:01, 31 December 2024
Immunosuppressive drugs such as the therapeutic monoclonal antibody daclizumab, ciclosporin, methotrexate and Adalimumab, sold under the trade name Humira...
11 KB (1,294 words) - 18:06, 2 July 2024
biological half-life of antibodies is typically on the order of days, see daclizumab and erenumab by way of example. To visualize and quantify the distribution...
74 KB (8,818 words) - 14:06, 11 December 2024
Antibody drugs: Monoclonal anti-IL-2Rα receptor antibodies Basiliximab Daclizumab Monoclonal anti-IL-6R receptor antibodies Tocilizumab Polyclonal anti-T-cell...
29 KB (3,272 words) - 16:03, 9 December 2024
hematology, and immunology.[citation needed] Investigational MS medicines: Daclizumab High-Yield Process (DAC HYP): is being developed as a potential once-monthly...
48 KB (3,837 words) - 18:51, 12 September 2024
L04AB05 Certolizumab pegol L04AB06 Golimumab L04AB07 Opinercept L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab...
3 KB (380 words) - 04:18, 23 December 2024
the humanized monoclonal antibody daclizumab, with Roche under a license that called for a 15% royalty. Daclizumab became the first humanized monoclonal...
6 KB (588 words) - 09:27, 15 August 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
63 KB (7,473 words) - 05:58, 16 October 2024
CORTICOSTEROIDS 135. COTRIMOXAZOLE 136. CYCLANDELATE 137. CYCLOSPORINS 138. DACLIZUMAB 139. DANAZOLE 140. DAPSONE 141. DESLORATADINE 142. DESMOPRESSIN 142. DESOGESTROL...
16 KB (253 words) - 16:47, 23 February 2023
to the graft. Anti-IL-2Rα receptor antibodies such as basiliximab and daclizumab are increasingly being used in place of ATG as an induction therapy, as...
8 KB (895 words) - 14:10, 23 August 2023
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
23 KB (1,840 words) - 07:04, 3 January 2025
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
15 KB (1,089 words) - 18:39, 16 October 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
17 KB (1,245 words) - 14:04, 2 September 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
24 KB (2,084 words) - 05:31, 21 October 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
9 KB (587 words) - 12:00, 30 September 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
42 KB (3,336 words) - 07:12, 27 December 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
50 KB (6,093 words) - 20:45, 19 November 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
14 KB (1,147 words) - 07:33, 11 August 2024
humanized CD70 cancer Dacetuzumab mab humanized CD40 hematologic cancers Daclizumab Zenapax mab humanized CD25 (α chain of IL-2 receptor) Y prevention of...
138 KB (4,154 words) - 05:18, 17 December 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
45 KB (4,194 words) - 12:36, 2 May 2024
to target specific cells by conjugating the ICG to antibodies such as daclizumab (Dac), trastuzumab (Tra), or panitumumab (Pan). ICG and laser therapy...
27 KB (2,788 words) - 15:31, 25 November 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
22 KB (2,581 words) - 20:03, 21 June 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
16 KB (1,451 words) - 18:24, 2 August 2024
Pegaldesleukin Teceleukin Tucotuzumab celmoleukin Antibodies: Basiliximab Daclizumab (dacliximab) Inolimomab IL-3 Agonists: Daniplestim Interleukin 3 Leridistim...
8 KB (483 words) - 19:43, 2 December 2024